WINNIPEG, MANITOBA--(Marketwire - Jan. 26, 2009) - DiaMedica Inc. (TSX VENTURE:DMA), a drug discovery and clinical development company focused on...
WINNIPEG, MANITOBA -- (Marketwire) -- 01/15/09 -- DiaMedica Inc. (TSX VENTURE: DMA), a drug discovery and clinical development company focused on...
WINNIPEG, MANITOBA--(Marketwire - Jan. 15, 2009) - DiaMedica Inc. (TSX VENTURE:DMA), a drug discovery and clinical development company focused on...
WINNIPEG, MANITOBA -- (Marketwire) -- 01/13/09 -- DiaMedica Inc. (TSX VENTURE: DMA), a drug discovery and clinical development company focused on...
WINNIPEG, MANITOBA--(Marketwire - Jan. 13, 2009) - DiaMedica Inc. (TSX VENTURE:DMA), a drug discovery and clinical development company focused on...
WINNIPEG, MANITOBA -- (Marketwire) -- 12/23/08 -- DiaMedica Inc. (TSX VENTURE: DMA), a drug discovery and clinical development company focused on...
WINNIPEG, MANITOBA -- (Marketwire) -- 10/16/08 -- DiaMedica Inc. (TSX VENTURE: DMA), a drug discovery and development company focused on a novel...
WINNIPEG, MANITOBA--(Marketwire - Sept. 30, 2008) - DiaMedica Inc. (TSX VENTURE:DMA), a drug discovery and development company focused on novel...
WINNIPEG, MANITOBA -- (Marketwire) -- 09/30/08 -- DiaMedica Inc. (TSX VENTURE: DMA), a drug discovery and development company focused on novel...
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 12, 2008) - TSX VENTURE COMPANIES ACTIVE GROWTH CAPITAL INC. ("ACK.P") BULLETIN TYPE:...
WINNIPEG, MANITOBA--(Marketwire - Aug. 11, 2008) - DiaMedica Inc. (TSX VENTURE:DMA), a drug discovery and clinical development company focused on...
WINNIPEG, MANITOBA -- (Marketwire) -- 08/11/08 -- DiaMedica Inc. (TSX VENTURE: DMA), a drug discovery and clinical development company focused on...
WINNIPEG, MANITOBA--(Marketwire - Aug. 7, 2008) - THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR...
WINNIPEG, MANITOBA--(Marketwire - July 30, 2008) - DiaMedica Inc. (TSX VENTURE:DMA), a drug discovery and development company focused on novel...
WINNIPEG, MANITOBA , a drug discovery and development company focused on novel treatments for Type 2 diabetes, announces that it will be...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.